PAD Profile : Milrinone lactate - Heart failure (children)

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Milrinone lactate - Heart failure (children)

PAD Profile : Milrinone lactate - Heart failure (children) Important

Important Information :

ASPH restricted to paediatrics. Off-label

Status :

Red

Formulations :

Trust Alignment :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

BNF NICE SPC

Comments :

No comments returned.

Documents :

No guidelines returned.

No additional documents returned.

Date

Committee Name

Narrative

07 August 2024

Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

02. Cardiovascular System

02.01.02. Phosphodiesterase Type-3 inhibitors